Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus
Abstract Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance, leading to elevated blood sugar levels. Exogenous insulin can counteract the diminished response to insulin and effectively controlling blood glucose levels, thereby minimizing diabetes-related comp...
Saved in:
| Main Authors: | Chan Yew Low, Wei Ling Gan, Su Jeat Lai, Rachel Su-May Tam, Jie Fei Tan, Stefanie Dietl, Lay Hong Chuah, Nicolas Voelcker, Athirah Bakhtiar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-024-03062-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
by: Vladimir A. Karpelyev, et al.
Published: (2018-03-01) -
Combination of a high-carbohydrate diet and streptozotoc in for modeling type 2 diabetes in Wistar rats
by: S. V. Ivanov, et al.
Published: (2023-07-01) -
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD
by: Tianyuan Yang, et al.
Published: (2025-04-01) -
Prescribing insulin in type 1 diabetes mellitus: an update for general practitioners
by: J.A. Dave, et al.
Published: (2007-12-01) -
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01)